A detailed history of Geneos Wealth Management Inc. transactions in Vericel Corp stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 271 shares of VCEL stock, worth $14,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
271
Previous 2,240 87.9%
Holding current value
$14,292
Previous $102,000 89.22%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.25 - $53.56 $83,190 - $105,459
-1,969 Reduced 87.9%
271 $11,000
Q2 2023

Aug 08, 2023

BUY
$29.0 - $38.37 $64,960 - $85,948
2,240 New
2,240 $84,000
Q1 2022

May 16, 2022

SELL
$31.69 - $43.29 $70,985 - $96,969
-2,240 Closed
0 $0
Q2 2020

Sep 07, 2021

BUY
$8.5 - $15.82 $8,500 - $15,820
1,000 Added 80.65%
2,240 $29,000
Q3 2019

Sep 07, 2021

SELL
$14.93 - $19.83 $104 - $138
-7 Reduced 0.56%
1,240 $18,000
Q2 2018

Sep 07, 2021

BUY
$9.6 - $14.6 $11,971 - $18,206
1,247 New
1,247 $12,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.49B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.